Veröffentlichungen
Monografien
- Resilience Stories: Individualized Tales of a Metanarrative. transcript Verlag, September 2021
Zeitschriftenartikel (double blind peer reviewed)
- Theis, S., Frühwein, H., Hasenburg, A. et al. From consultation to choice: gynecologic cancer patients’ perspectives on shared decision making in clinical practice – findings from a cross-sectional observational qualitative interview study. BMC Med Ethics 27, 46 (2026). doi.org/10.1186/s12910-026-01419-1
- Frühwein H, Theis S, Neu M, Alt F. (2026). Applying the 5P framework to improve cancer prevention in European health systems. J Public Health Policy. 47(2):239-262. https:// doi.org/10.1057/s41271-026-00627-8.
- Theis, S., Pavicic, E., Estermann, J., Bitterlich, N., Frühwein, H., & Petra Stute. Unmet clinical needs in women with polycystic ovary syndrome regarding chronic non-communicable diseases: A cross‑sectional study. Arch Gynecol Obstet 313, 21 (2026). https://doi.org/10.1007/s00404-025-08287-x.
- Alt, F., Neu, M.A., Frühwein, H., Bozzaro, C., Faber, J., & Norbert W. Paul. (2026). Death wishes and death thoughts in paediatric palliative care: a survey of German healthcare professionals. BMC Palliat Care 25, 23 https://doi.org/10.1186/s12904-025-01973-2.
- Frühwein H, Münch N, Paul NW. (2026). Reassessing onco-exceptionalism: equity and resource allocation in immunotherapeutic cancer treatments. J Med Ethics. 22;52(2):100-105. https:// doi.org/10.1136/jme-2025-110739.
- Theis, S., Frühwein, H., Hasenburg, A. et al. (2025). Patient needs in the context of gynecologic oncology and breast cancer: a validation study. Sci Rep 15, 32703 https://doi.org/10.1038/s41598-025-20816-x
- Frühwein, H. (2025). Reframing Language in Bioethics: Strengths and Gaps in the Pragmatic Turn. The American Journal of Bioethics, 25(4), 88–89. https://doi.org/10.1080/15265161.2025.2470651.
- Frühwein, H., Paul, N.W. “Lost in translation?” (2025). Animal research in the era of precision medicine. J Transl Med 23, 152 (2025). https://doi.org/10.1186/s12967-025-06084-3.
- Mahdiani, H., Münch, N. & Paul, N. W. (2024). A QALY is [still] a QALY is [still] a QALY?: Evaluating proportional shortfall as the answer to the problem of equity in healthcare allocations. BMC Medical Ethics, 25(1). doi.org/10.1186/s12910-024-01036-w.
- Paul, N. W., Münch, N., & Mahdiani, H. (2023). Zur (De-)Differenzierung von Prädiktion und Prävention: Begriffliche und ethische Überlegungen [On the (De)differentiation of Prediction and Prevention: Conceptual and Ethical Considerations]. Zeitschrift für medizinische Ethik 69(3), 333-355. doi.org/10.30965/29498570-20230031
- Resilience Stories: Individualized Tales of a Metanarrative. transcript Verlag, September 2021
- Mahdiani H., Ungar, M. (2021). The Dark Side of Resilience. Journal of Adversity and Resilience Science. doi.org/10.1007/s42844-021-00031-z
- Mahdiani, H., Ungar, M. (2020). Can Biomedical and Cognitive Enhancement Increase Psychological Resilience? Journal of Canadian psychology. doi.org/10.1037/cap0000217
- Mahdiani, H., Höltge, J., Theron, L. et al. (2020). Resilience in Times of Economic Boom and Bust: A Narrative Study of a Rural Population Dependent upon the Oil and Gas Industry. J Adult Dev. doi.org/10.1007/s10804-020-09363-z
- Münch, N., Mahdiani, H., Lieb, K. et al. (2020). Resilience beyond reductionism: ethical and social dimensions of an emerging concept in the neurosciences. Med Health Care and Philos. doi.org/10.1007/s11019-020-09981-0
- Mahdiani, Hamideh. (2020). "Old Book, New Look: Exploring Resilience and Self-Help in The Power of Sympathy and Educated". International Journal of English Literature and Social Sciences (IJELS) 5 (4). journal-repository.com/index.php/ijels/article/view/2354.
- Joodaki, A.H., Mahdiani, H. (2016). Gravity's Rainbow in the light of speech act theory. Neohelicon 43, 279-291.
Zeitschriften- und Sammelbandartikel (editor or peer reviewed)
- Mahdiani, Hamideh (2024). HPR221 Revisiting Healthcare Resource Allocation for Immunotherapeutic Treatments in Cancer. Value in Health. 27(12). https://doi.org/10.1016/j.jval.2024.10.1645
- Frühwein, Hamideh. (2026). From Precision Medicine to Precision Health: Preventive Care and Equity in an Ageing Society. World Medical Journal, 2(72).
Eingeworbene (Dritt-)Mittel und Förderanträge
- Anschubfinanzierung zur Entwicklung eines Postdoktorandenprojekts und zur Einwerbung von Drittmitteln, gefördert durch das DFG-Graduiertenkolleg „Life Sciences – Life Writing“ und die Johannes Gutenberg-Universität Mainz, 03.2020–04.2021; Fördersumme: 50.000 €.
- Promotionsstipendium der Deutschen Forschungsgemeinschaft (DFG), 04.2017–03.2020; Fördersumme: 52.000 €.
- ERA-NET NEURON; Projekttitel: „NeuREthics“; Antragssumme: 545.931,45 €; geplante Laufzeit: 04.2021–03.2024
- Europäische Kommission; Projekttitel: „DaSiRe“; Antragssumme: 219.000 €; geplante Laufzeit: 07.2021–06.2023
- DFG, Walter-Benjamin-Programm (eigene Stelle); Projekttitel: „The Dark Side of Resilience“; Antragssumme: durch die DFG berechnet
- Alexander-von-Humboldt-Stiftung, Feodor-Lynen-Programm (eigenständige Forschungsstelle); Projekttitel: „EQUIP Health: Empowering Equity in Proactive Healthcare (EQUIP)“; Projektlaufzeit: 01.2026–12.2028
- Wissenschaftskommunikation - BMBF; Förderbereich: Wissenschaftsjahr 26; Therapieziele realistisch kommunizieren? Informationsdissonanzen und Erwartungshorizonte in der Reproduktionsmedizin aus Sicht heterosexueller und gleichgeschlechtlicher Patient:innen - ein partizipatives Projekt zur inklusiven Wissenschaftskommunikation; INFO-REAL; Online-Kennung: 100735808; 01.04.2026-30.12.2026; 79.000,00 €
- Sachbeihilfe; DFG; Responsibility in Reproductive Medicine under Structural Inequality: RePro; geplante Laufzeit: 01.01.2027- 30.12.2029; 500.000,00 € (in Gutachten)
Vorträge
- 11.2026. the 19th European Public Health Conference on “Urban and global synergies: shaping the future of public health with climate resilience, equity and innovation”, Bilbao, Spain
- 08.2026, Applying the 5P Framework to Improve Cancer Prevention in European Health Systems, 38th European Conference on Philosophy of Medicine and Health Care Rotterdam, 25-28 August 2026
- 11.2025. From Precision Medicine to Precision Health: Preventive Care and Equity in an Aging Society, 17th World Conference Bioethics, Medical Ethics and Health Law, Ljubljana 24-26 November 2025
- 11.2026. ISPOR Europe; Barcelona, Spain
- 08.2024. Onco-exceptionalism in precision medicine. 36th European Conference on Philosophy of Medicine & Health Care :Methods in Bioethics and Philosophy of Medicine, Offenbach, Germany
- 10.2023. Application of Immunotherapy in the treatment of NSCLC: Ethical perspectives on the cost-effectiveness justification and evaluation, Institute of Translational Immunology ERA PerMed Mini-Symposium, Universitätsmedizin Mainz
- 08.2023. Ethical Perspectives on the Traditional Cost-effectiveness Evaluation: Application of Immunotherapy in the Treatment of NSCLC, 35th European Conference on Philosophy of Medicine & Health Care :Methods in Bioethics and Philosophy of Medicine, Riga, Lettland
- 04.2021. Resilience in Times of Economic Boom and Bust: A Narrative Study, Leibniz center for resilience studies, university medical center Mainz.
- 05.2019. Multisystemic perspective on Narratives of Resilience, Dalhousie University, Halifax, Canada
- 11.2018. Expert Meeting: Hidden Narratives: From Crisis Response to Social Resilience, free University of Amsterdam, Netherlands.
- 09.2018. Narratives of Resilience, Young Researcher's Talk at the International Resilience Symposium (former DRZ, now Leibniz centre for Resilience Research), Mainz, Germany
- 08.2018. Enhancement and Human Agency, a conference talk at European Society for Medicine, Philosophy and Health, 2018, Lisbon (With Nikolai Münch)
- 04.2018. Resilience and Narratives, a project presentation at Resilience Spring School, organized by Leibniz center for Resilience Research, funded by German Research Foundation, Kloster Seeon, Bavaria, 2018
Gutachtertätigkeit
- Nature (mental health); Springer (jounal of adversity and resilience science); Springer (SSM, population health); ISPOR Value in Health;
